Abstract:Abstract Vitamin K is a lipophilic vitamin, whose absorption, transportation, and distribution are influenced by lipids. The plasma vitamin K level after supplementation is predominantly a lipid-driven effect and independent of existing vitamin K status. However, previous studies examining the efficacy of vitamin K supplementation often overlooked the influence of lipid levels on vitamin K absorption, resulting in inconsistent outcomes. Recent research discovered that impaired transportation of vitamin K2 within uremic high-density lipoproteins (HDL) in individuals with uremia might elucidate the lack of beneficial effects in preventing calcification observed in multiple trials involving menaquinone-7 (MK-7) supplementation among patients with chronic kidney disease. Clinical findings have shown that drugs used to regulate hyperlipidemia interact with the vitamin K antagonist warfarin, because cholesterol and vitamin K share common transport receptors, such as Niemann-Pick C1-like 1 (NPC1L1) and ATP-binding cassette protein G5/G8 (ABCG5/ABCG8), in enterocytes and hepatocytes. Additionally, cholesterol and vitamin K share a common biosynthetic intermediate called geranylgeranyl pyrophosphate (GGPP). It is important to note that statins, which hinder cholesterol synthesis, can also impede vitamin K conversion, ultimately impacting the functionality of vitamin K-dependent proteins. Furthermore, certain studies have indicated that vitamin K supplementation holds potential in managing hyperlipidemia, potentially opening a novel avenue for controlling hyperlipidemia using dietary vitamin K supplements. Therefore, attaining a more comprehensive understanding of the intricate interplay between vitamin K and lipids will yield valuable insights concerning the utilization of vitamin K and lipid regulation.

What problem does this paper attempt to address?

### Problems the Paper Attempts to Address This paper aims to explore the interaction between vitamin K and lipid metabolism and its implications for clinical applications. Specifically, the paper focuses on the following aspects: 1. **Absorption and Transport of Vitamin K**: - Vitamin K is a fat-soluble vitamin, and its absorption, transport, and distribution are influenced by lipids. The levels of vitamin K in plasma after supplementation are primarily driven by lipids and are independent of the existing vitamin K status. However, previous studies on the effects of vitamin K supplementation often overlooked the impact of lipid levels on vitamin K absorption, leading to inconsistent results. 2. **Vitamin K Transport Impairment in Uremic Patients**: - Recent studies have found that in the high-density lipoprotein (HDL) of uremic patients, the transport of vitamin K2 (MK-7) is impaired, which may be one of the reasons it cannot effectively prevent vascular calcification. This phenomenon explains the clinical trial results in chronic kidney disease (CKD) patients, where MK-7 supplementation did not significantly improve vascular calcification. 3. **Interaction Between Cholesterol-Regulating Drugs and Vitamin K**: - There is an interaction between cholesterol-regulating drugs and the vitamin K antagonist warfarin because cholesterol and vitamin K share the same transport receptors (such as NPC1L1 and ABCG5/ABCG8). Additionally, cholesterol and vitamin K share a common biosynthetic intermediate—geranylgeranyl pyrophosphate (GGPP). Studies have shown that statins, which inhibit cholesterol synthesis, also hinder the conversion of vitamin K, affecting the function of vitamin K-dependent proteins. 4. **Potential of Vitamin K Supplements in Regulating Blood Lipids**: - Some studies suggest that vitamin K supplements may help manage hyperlipidemia, providing a new approach to controlling hyperlipidemia through dietary supplements. For example, in patients with polycystic ovary syndrome (PCOS), vitamin K supplements can significantly reduce serum triglyceride levels and decrease waist circumference and body fat mass. In summary, this paper proposes the potential mechanisms of vitamin K supplements in clinical applications and their prospects for managing hyperlipidemia by studying the relationship between vitamin K and lipid metabolism. By deeply understanding the complex interactions between vitamin K and lipids, the application of vitamin K can be better guided, and new ideas for hyperlipidemia intervention can be provided.

Revisiting the interconnection between lipids and vitamin K metabolism: insights from recent research and potential therapeutic implications: a review

Vitamin K metabolism and nutriture

The Role of Vitamin K in CKD-MBD

Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: an important but poorly studied relationship

The biological responses of vitamin K2: A comprehensive review

The Potential of Vitamin K as a Regulatory Factor of Bone Metabolism—A Review

Vitamin K2 in Health and Disease: A Clinical Perspective

Key Pathways and Regulators of Vitamin K Function and Intermediary Metabolism.

Vitamin K for Vascular Calcification in Kidney Patients: Still Alive and Kicking, but Still a Lot to Learn

Beyond the Coagulation Cascade: Vitamin K and Its Multifaceted Impact on Human and Domesticated Animal Health

Physiological and Cellular Functions of Vitamin K on Cardiovascular Function

Vitamin K : A Micro-Nutrient with New Perspective

Vitamin K Supplementation for Prevention of Vascular Calcification in Chronic Kidney Disease Patients: Are We There Yet?

Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evidence? A Systematic Review of Controlled Trials

The Relationships Between Vitamin K and Cognition: A Review of Current Evidence

Relationship between Structure and Biological Activity of Various Vitamin K Forms

Vitamin K: A Simple and Efficient Add-on to the Current Treatment Regime of COVID-19

Effect of vitamin K in bone metabolism and vascular calcification: A review of mechanisms of action and evidences

Vitamin K as a Diet Supplement with Impact in Human Health: Current Evidence in Age-Related Diseases

The Dual Role of Vitamin K2 in “Bone-Vascular Crosstalk”: Opposite Effects on Bone Loss and Vascular Calcification

Vitamin K supplementation in chronic kidney disease patients: where is the evidence?